Found: 17
Select item for more details and to access through your institution.
One‐year outcomes with ustekinumab therapy in infliximab‐refractory paediatric ulcerative colitis: a multicentre prospective study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 12, p. 1300, doi. 10.1111/apt.16388
- By:
- Publication type:
- Article
Editorial: total anti‐drug antibodies detected using drug‐tolerant assays during induction with anti‐TNF therapy are associated with treatment failure—out of sight but not out of mind. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 12, p. 1319, doi. 10.1111/apt.16399
- By:
- Publication type:
- Article
Letter: the use of magnetic resonance scores (Anali) for risk stratification in PSC—authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 12, p. 1331, doi. 10.1111/apt.16397
- By:
- Publication type:
- Article
Letter: budesonide for functional dyspepsia with duodenal eosinophilia—randomised, double‐blind, placebo‐controlled parallel‐group trial.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 12, p. 1332, doi. 10.1111/apt.16396
- By:
- Publication type:
- Article
Editorial: microscopic colitis linked to NSAIDs but not proton pump inhibitors.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 12, p. 1324, doi. 10.1111/apt.16390
- By:
- Publication type:
- Article
Letter: risk of coeliac disease—do microbial derived factors promote and protect? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 12, p. 1328, doi. 10.1111/apt.16389
- By:
- Publication type:
- Article
Editorial: determining disability in inflammatory bowel disease—"See(k) and you shall find". Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 12, p. 1323, doi. 10.1111/apt.16384
- By:
- Publication type:
- Article
Pretreatment non‐hypervascular hypointense nodules on Gd‐EOB‐DTPA‐enhanced MRI as a predictor of hepatocellular carcinoma development after sustained virologic response in HCV infection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 12, p. 1309, doi. 10.1111/apt.16382
- By:
- Publication type:
- Article
Review article: the role of nutrition in alcohol‐associated liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 12, p. 1268, doi. 10.1111/apt.16380
- By:
- Publication type:
- Article
Letter: the use of magnetic resonance scores (Anali) for risk stratification in PSC.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 12, p. 1329, doi. 10.1111/apt.16378
- By:
- Publication type:
- Article
Comparison of short‐ and long‐term effectiveness between ustekinumab and vedolizumab in patients with Crohn's disease refractory to anti‐tumour necrosis factor therapy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 12, p. 1289, doi. 10.1111/apt.16377
- By:
- Publication type:
- Article
Review article: diagnosis, management and patient perspectives of the spectrum of constipation disorders.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 12, p. 1250, doi. 10.1111/apt.16369
- By:
- Publication type:
- Article
Editorial: determining disability in IBD – 'See(k) and you shall find'.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 12, p. 1321, doi. 10.1111/apt.16367
- By:
- Publication type:
- Article
Clinical outcome after anti‐tumour necrosis factor therapy discontinuation in 1000 patients with inflammatory bowel disease: the EVODIS long‐term study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 12, p. 1277, doi. 10.1111/apt.16361
- By:
- Publication type:
- Article
Editorial: total anti‐drug antibodies detected using drug‐tolerant assays during induction with anti‐TNF therapy are associated with treatment failure—out of sight but not out of mind.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 12, p. 1317, doi. 10.1111/apt.16359
- By:
- Publication type:
- Article
Letter: risk of coeliac disease—do microbial‐derived factors promote and protect?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 12, p. 1326, doi. 10.1111/apt.16348
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 12, p. 1247, doi. 10.1111/apt.15849
- Publication type:
- Article